Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents

被引:130
作者
Zona, C
Niespodziany, I
Marchetti, C
Klitgaard, H
Bernardi, G
Margineanu, DG
机构
[1] UCB SA Pharma Sector, R&D, Preclin CNS Res, B-1420 Braine Alleud, Belgium
[2] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy
[3] IRCCS, Fdn S Lucia, Rome, Italy
来源
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 2001年 / 10卷 / 04期
关键词
levetiracetam; antiepileptic drugs; sodium current; low-voltage-gated calcium current; rat;
D O I
10.1053/seiz.2000.0504
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study investigated whether the mechanism of action of levetiracetam (LEV) is related to effects on neuronal voltage-gated Na+ or T-type Ca2+ currents. Rat neocortical neurones in culture were subjected to the whole-cell mode of voltage clamping under experimental conditions designed to study voltage-gated Naf current. Additionally, visually identified pyramidal neurones in the CA1 area of rat hippocampal slices were subjected to the whole-cell mode of voltage clamping under experimental conditions designed to study low-voltage-gated (T-type) Ca2+ current. LEV (10 muM-1 mM) did not modify the Na+ current amplitude and did not change (200 muM) the steady-state activation and inactivation, the time to peak, the fast kinetics of the inactivation and the recovery from the steady-state inactivation of the Na+ current. Likewise, LEV (32-100 muM) did not modify the amplitude and did not change the steady-state activation and inactivation, the time to peak, the fast kinetics of the inactivation and the recovery from the steady-state inactivation of the T-type Ca2+ current. In conclusion, neuronal voltage-gated Na+ channels do not appear directly involved in the antiepileptic mechanism of action of LEV, and LEV was devoid of effect on the low-voltage-gated (T-type) Ca2+ current in hippocampal neurones. (C) 2001 BEA Trading Ltd.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 31 条
[1]  
Barton M. E., 1999, Society for Neuroscience Abstracts, V25, P1115
[2]   Levetiracetam (ucb L059) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission [J].
Birnstiel, S ;
Wulfert, E ;
Beck, SG .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (05) :611-618
[3]   CHARACTERIZATION OF ETHOSUXIMIDE REDUCTION OF LOW-THRESHOLD CALCIUM CURRENT IN THALAMIC NEURONS [J].
COULTER, DA ;
HUGUENARD, JR ;
PRINCE, DA .
ANNALS OF NEUROLOGY, 1989, 25 (06) :582-593
[4]  
FRAZER CM, 1997, EPILEPSIA S3, V38, P177
[6]   UCB L059, A NOVEL ANTICONVULSANT DRUG - PHARMACOLOGICAL PROFILE IN ANIMALS [J].
GOWER, AJ ;
NOYER, M ;
VERLOES, R ;
GOBERT, J ;
WULFERT, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 222 (2-3) :193-203
[7]   Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy [J].
Gower, AJ ;
Hirsch, E ;
Boehrer, A ;
Noyer, M ;
Marescaux, C .
EPILEPSY RESEARCH, 1995, 22 (03) :207-213
[8]  
Hans G., 2000, Epilepsia, V41, P35
[9]   Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy [J].
Klitgaard, H ;
Matagne, A ;
Gobert, J ;
Wülfert, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 353 (2-3) :191-206
[10]  
Leresche N, 1998, J NEUROSCI, V18, P4842